Articles related to INFLUENZA

Based on the data presented, the committee agreed that there was a need to change the influenza A/H3N2 virus strains from the 2024-2025 formula.

Antiviral therapy initiated within 48 hours of symptom onset can reduce illness duration by 1-2 days, highlighting the importance of early recognition and intervention in high-risk populations.

N-acetylcysteine intervention within the crucial 8-hour window provides nearly 100% effective treatment for acetaminophen overdose cases, making rapid recognition and response essential.

Guidelines from the CDC and AHA emphasize the critical role of vaccinations in protecting cardiac patients against the heightened risk of severe complications from infections like influenza and RSV, advocating for a comprehensive vaccination strategy.

Recent studies have indicated a potential increase in stroke risk among seniors, particularly those aged 85 and older, who receive both COVID-19 and influenza vaccines simultaneously. This finding has sparked a renewed focus on the safety of administering multiple vaccines at the same time.

The recent phase 1/2 study of Pfizer-BioNTech’s combination vaccine candidate demonstrated robust immune responses to influenza A, influenza B, and SARS-CoV-2 strains. This promising development could significantly impact global immunization practices.